Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-06

Clinical Trial Update: Tecovirimat (ST-246) Treatment for Orthopox Virus Exposure

View source ↗

Summary

Clinical trial update for the antiviral Tecovirimat (ST-246) used to treat exposure to orthopoxviruses, including smallpox and monkeypox; the study status is AV…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TPOXX (tecovirimat monohydrate)

Snippet

Sponsor: U.S. Army Medical Research and Development Command | Conditions: Smallpox, Monkeypox | Status: AVAILABLE